Welcome to the Pomerantz LLP Blog! Pomerantz LLP Investigating Claims Against Sangamo Therapeutics, Inc. January 26, 2025 Here at Pomerantz LLP, we take pride in representing investors in cases of corporate misconduct and securities fraud. Currently, we are investigating claims on behalf of investors of Sangamo Therapeutics, Inc. (“Sangamo” or the “Company”) listed on the…
Breaking News: Class Action Lawsuit Filed Against BioAge Labs, Inc. What’s Going On? Well, folks, it looks like BioAge Labs, Inc. is in some hot water. Pomerantz LLP has announced that a class action lawsuit has been filed against the company. That’s right, BioAge is facing some legal troubles and investors are advised to take…
Welcome to the Construction Zone: A Rollercoaster Ride for Investors Hold on to your hard hats, folks! Pomerantz LLP is on the case. Hey there, investors! If you’ve got your money in Construction Partners, Inc. (NASDAQ:ROAD), you might want to pay attention to this. Pomerantz LLP is currently looking into some claims that could shake…
Welcome to the Jungle: A Wild Investigation into Franklin Resources, INC. The Setting: New York, NY / ACCESS Newswire / January 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Franklin Resources, INC. (“Franklin” or the “Company”) (NYSE:BEN) The Plot Thickens: Well folks, it looks like we’ve got ourselves a good…
Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc. New York City, NY / ACCESS Newswire / January 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ:KYTX). Investors who have purchased shares of Kyverna Therapeutics, Inc. are advised to contact Danielle Peyton…
Investigation into Alto Neuroscience, Inc. and Its Impact on Investors January 26, 2025 LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alto Neuroscience, Inc. (“Alto Neuroscience” or “the Company”) (NYSE:ANRO) for…
Welcome to the Symbotic Inc. Investment Woes Blog! Did you recently suffer a loss on your Symbotic Inc. (NASDAQ:SYM) investment? You’re not alone! Hey there, fellow investor! If you’ve found yourself in a pickle after investing in Symbotic Inc., fear not! You may have a chance for recovery under the federal securities laws. Intrigued? Read…
Recovering Losses on Your Novo Nordisk A/S Investment Introduction For those who have recently suffered losses on their Novo Nordisk A/S (NYSE:NVO) investment, there may be potential opportunities for recovery under federal securities laws. If you find yourself in this situation, it’s essential to understand your rights and options moving forward. Understanding the Situation It…
